Skip to main content
SpringerLink
Log in

Neuroprotective effects of riluzole in Huntington’s disease

  • Letter to the editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Bergerot A, Shortland PJ, Anand P, et al. Co-treatment with riluzole and GDNF is necessary for functional recovery after ventral root avulsion injury. Exp Neurol 2004;187:359–66.

    Article  PubMed  CAS  Google Scholar 

  2. Katoh-Semba R, Asano T, Ueda H, et al. Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus. FASEB J 2002;16:1328–30.

    PubMed  CAS  Google Scholar 

  3. Gauthier LR, Charrin BC, Borrell-Pages M, et al. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 2004;118:127–38.

    Article  PubMed  CAS  Google Scholar 

  4. Ciammola A, Sassone J, Cannella M, et al. Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington’s disease patients. Am J Med Genet B Neuropsychiatr Genet 2007;144B:574–7.

    Article  CAS  Google Scholar 

  5. Ciarmiello A, Cannella M, Lastoria S, et al. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington’s disease. J Nucl Med 2006;47:215–22.

    PubMed  CAS  Google Scholar 

  6. Alfano B, Brunetti A, Covelli EM, et al. Unsupervised, automated segmentation of the normal brain using a multispectral relaxometric magnetic resonance approach. Magn Reson Med 1997;37:84–93.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We thank all patients and their families (Associazione Italiana Corea di Huntington-Neuromed). The financial support of Telethon-Italy to FS (Grant No. GGP06181), is gratefully acknowledged.

Author information

Authors and Affiliations

  1. IRCCS Neuromed, Pozzilli, Isernia, Italy

    Ferdinando Squitieri & Claudio Colonnese

  2. Department of Neurology and Laboratory of Neuroscience, “Dino Ferrari” Center, IRCCS Istituto Auxologico Italiano, Milan, Italy

    Andrea Ciammola

  3. Nuclear Medicine Unit, IRCCS Pascale, Naples, Italy

    Andrea Ciarmiello

  4. Neurogenetics Unit, IRCCS Neuromed, Centre for Rare Diseases, Località Camerelle, 86077, Pozzilli, Isernia, Italy

    Ferdinando Squitieri

Authors
  1. Ferdinando Squitieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrea Ciammola
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Claudio Colonnese
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andrea Ciarmiello
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ferdinando Squitieri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Squitieri, F., Ciammola, A., Colonnese, C. et al. Neuroprotective effects of riluzole in Huntington’s disease. Eur J Nucl Med Mol Imaging 35, 221–222 (2008). https://doi.org/10.1007/s00259-007-0615-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-007-0615-y

Keywords

Search

Navigation